SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Earnings before interest, taxes, depreciation, and amortization
5Y CAGR
-3.5%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $17.67M | +160.9% |
| 2024 | $-28.99M | +24.0% |
| 2023 | $-38.13M | -152.2% |
| 2022 | $-15.12M | +0.5% |
| 2021 | $-15.20M | -171.9% |
| 2020 | $21.14M | +356.7% |
| 2019 | $-8.23M | - |